IMCD stock: IMCD schedules November 5, 2026 results
Published on 10/20/2026 at 15:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting calendar
- IMCD will publish its first nine months 2026 results on November 5, 2026.
- First-half 2026 EBITA reached EUR 285.00 million, up 8.00 percent on a constant-currency basis.
- IMCD stock costs EUR 101.68 at Lang & Schwarz on October 20, 2026 at 3:01 p.m. CEST, down 1.52 percent versus the Xetra close of October 19, 2026.
IMCD will publish its first nine months 2026 results on November 5, 2026, giving investors the next scheduled checkpoint for the specialty chemicals distributor. The date was announced by GlobeNewswire on October 15, 2026. At Lang & Schwarz, the stock was trading at EUR 101.68 on October 20, 2026 at 3:01 p.m. CEST, down 1.52 percent versus the Xetra close of October 19, 2026 at EUR 103.25.
November 5 sets the next test
The upcoming release will cover the first nine months of 2026, followed by an analyst conference call and webcast at 9:00 a.m. CET. The publication is scheduled for 7:00 a.m. CET, according to GlobeNewswire. The event matters because the first-half figures showed stronger operating momentum after a weak start to the year.
In the first half of 2026, IMCD reported EBITA of EUR 285.00 million, up 8.00 percent on a constant-currency basis. Gross profit reached EUR 658.00 million, an increase of 7.00 percent, while revenue rose 11.00 percent on an exchange-rate-adjusted basis, according to the Yahoo Finance transcript of the July 29, 2026 results call.
Where the stock trades today
IMCD's EUR 101.68 price stands 3.67 percent below its 52-week high of EUR 105.55 and 49.23 percent above its 52-week low of EUR 68.14. The market capitalization is EUR 6.0 billion, while the price-to-earnings ratio is 26.09 as of October 20, 2026. The stock has traded below its yearly high even as the half-year report showed 7.00 percent constant-currency gross profit growth.
What dates matter for valuation?
The November 5 report is the next scheduled corporate date. IMCD's investor calendar also lists full-year 2026 results for February 19, 2027, followed by the annual report on March 4, 2027, according to IMCD. The company reported EUR 222.00 million of free cash flow in the first half, up EUR 49.00 million from the same period a year earlier, according to the Yahoo Finance transcript.
IMCD's operating picture therefore combines an 11.00 percent exchange-rate-adjusted revenue increase with an 8.00 percent EBITA increase in the first half of 2026. The November release will indicate whether that improvement continued into the third quarter.
IMCD stock remains below its yearly high
The stock was trading at EUR 101.68 at Lang & Schwarz on October 20, 2026 at 3:01 p.m. CEST, down 1.52 percent versus the Xetra close of October 19, 2026 at EUR 103.25. It was 3.67 percent below the 52-week high of EUR 105.55.
The further course of trading is shown by the continuously updated real-time quote of IMCD stock.
IMCD stock key facts
- Company: IMCD N.V.
- ISIN: NL0010801007
- Ticker: IMCD
- Primary exchange: Euronext Amsterdam
- Price Lang & Schwarz (as of October 20, 2026, 3:01 p.m. CEST): EUR 101.68
- Change versus Xetra close: minus 1.52 percent
- Xetra close (October 19, 2026): EUR 103.25
- Market capitalization: EUR 6.0 billion (as of October 20, 2026)
- 52-week range: EUR 68.14-105.55 (as of October 20, 2026)
- Sector / Industry: Specialty chemicals distribution
- Index membership: Dutch ESG AEX
- Next earnings date: November 5, 2026
Market context: Market report AEX.
